D.E. Shaw & Co’s PhenomeX Inc. Common Stock CELL Stock Holding History

D.E. Shaw & Co’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40,000	Closed	-$727K	–	6112
2021 Q4	$727K	Buy	+40,000	New	+$863K	﹤0.01%	4161

D.E. Shaw & Co's CELL Position: Q4 2023 in Review

D.E. Shaw & Co sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 148,923 shares — an estimated $149K sold.

D.E. Shaw & Co first reported a position in CELL in Q4 2020 and held it in 8 quarters. The position peaked at $2.91M in Q4 2022. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

D.E. Shaw & Co reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
D.E. Shaw & Co sold 148,923 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $149K.
D.E. Shaw & Co first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 8 quarters.
D.E. Shaw & Co's PhenomeX Inc. Common Stock position peaked at $2.91M in Q4 2022.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.